Caption Management »

Rapt Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0M 201k 24.85
2022-06-30 $812k 45k 18.25
2021-12-31 $2.3M 62k 36.72
2021-09-30 $1.1M 37k 31.04
2021-06-30 $39M 1.2M 31.79

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Rapt Therapeutics

T. Rowe Price Associates
Column Group
Perceptive Advisors
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Kingdon Capital Management
Samlyn Capital
Euclidean Capital
Alphabet
Cormorant Asset Management
Dimensional Fund Advisors
Millennium Management
Citadel Advisors
Braidwell
Redmile Group

View all funds holding Rapt Therapeutics